DOACs and Drug Interactions in Transplant Patients – JTH
Journal of Thrombosis and Haemostasis shared a post on LinkedIn about a recent article by Andreas Verstraete et al., adding:
“Direct oral anticoagulant use and drug-drug interactions in transplant recipients receiving calcineurin inhibitors.
Cyclosporine and tacrolimus inhibit the CYP3A4 and P-glycoprotein pathways that clear DOACs, raising concern about elevated drug levels.
Among 216 transplant recipients with 360 DOAC measurements, 11% were above-range, more often with rivaroxaban (20%) and apixaban (18%) than edoxaban (4%).
Higher levels tracked with strong CYP3A4 or P-glycoprotein inhibitors, lower weight, reduced kidney function, and cyclosporine use.”
Title: Direct oral anticoagulant use and drug-drug interactions in transplant recipients receiving calcineurin inhibitors
Authors: Andreas Verstraete, Erwin Dreesen, Quentin Van Thillo, Margot Erard, Dirk R.J. Kuypers, Marc Jacquemin, Filip Rega, Johan Van Cleemput, Jef Verbeek, Robin Vos, Peter Verhamme, Lorenz Van der Linden, Thomas Vanassche

Other posts about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health